- Home
- NRXP vs APYX Comparison
NRXP vs APYX Comparison
Compare NRXP & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- APYX
- Stock Information
- Founded
- NRXP 2015
- APYX 1982
- Country
- NRXP United States
- APYX United States
- Employees
- NRXP N/A
- APYX N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- NRXP Health Care
- APYX Health Care
- Exchange
- NRXP Nasdaq
- APYX Nasdaq
- Market Cap
- NRXP 34.7M
- APYX 36.2M
- IPO Year
- NRXP N/A
- APYX 1987
- Fundamental
- Price
- NRXP $1.98
- APYX $0.90
- Analyst Decision
- NRXP Strong Buy
- APYX Hold
- Analyst Count
- NRXP 4
- APYX 2
- Target Price
- NRXP $28.25
- APYX N/A
- AVG Volume (30 Days)
- NRXP 128.2K
- APYX 68.5K
- Earning Date
- NRXP 05-13-2025
- APYX 05-08-2025
- Dividend Yield
- NRXP N/A
- APYX N/A
- EPS Growth
- NRXP N/A
- APYX N/A
- EPS
- NRXP N/A
- APYX N/A
- Revenue
- NRXP N/A
- APYX $48,102,000.00
- Revenue This Year
- NRXP N/A
- APYX $1.85
- Revenue Next Year
- NRXP N/A
- APYX $7.72
- P/E Ratio
- NRXP N/A
- APYX N/A
- Revenue Growth
- NRXP N/A
- APYX N/A
- 52 Week Low
- NRXP $1.10
- APYX $0.76
- 52 Week High
- NRXP $6.01
- APYX $1.99
- Technical
- Relative Strength Index (RSI)
- NRXP 48.76
- APYX 38.57
- Support Level
- NRXP $1.85
- APYX $0.89
- Resistance Level
- NRXP $1.97
- APYX $1.02
- Average True Range (ATR)
- NRXP 0.16
- APYX 0.15
- MACD
- NRXP 0.03
- APYX -0.00
- Stochastic Oscillator
- NRXP 71.43
- APYX 31.16
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.